Company intelligence / Profile preview

Endeavor Venture Funds

Switzerland

Ownership: Private
Employees: ~22
Development stage: Other

Overview

No specific clinical results directly attributed to the fund (as it is an investor), but it has invested in highly successful innovators such as Moderna and 94 other companies with groundbreaking healthcare technologies

Therapeutic areas: OncologyOtherRare Diseases
Modalities: Small moleculeGene therapyBiotechnologyMedical deviceWearable sensorsDigital health (AI/ML-enabled platforms, digital therapeutics)mRNA-based drugsPrecision medicineMolecular biomarker
Industry: Investors

Partnerships

Prominent academic collaborations (Harvard, MIT, Boston University, McGill University, NYU, Columbia University)Partnerships with Fortune 500 companiesBig Tech (cloud, AI)Big PharmaBiotechMedtechHealthtechcorporate accelerators (e.g., Future4Care with Sanofi, Capgemini, Orange, Generali)

Beyond the preview

Go deeper on Endeavor Venture Funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endeavor Venture Funds.

Explore the full profile